Integrating systems biology sources illuminates drug action

Clinical Pharmacology and Therapeutics

Volumn 95, Issue 6, 2014, Pages 663-669

  Gottlieb, A ^a   Altman, R B ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b Stanford University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; DRUG DNA INTERACTION; DRUG MECHANISM; DRUG REPOSITIONING; DRUG RESPONSE; GENE INTERACTION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; SIDE EFFECT; SYSTEMS BIOLOGY;

ALGORITHMS; DATABASES, FACTUAL; DRUG INTERACTIONS; DRUG REPOSITIONING; GENE REGULATORY NETWORKS; HUMANS; PHARMACOGENETICS; PHARMACOLOGY; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 84901236897     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2014.51     Document Type: Article

References (49)

1. Lu, J.J., Pan, W., Hu, Y.J. & Wang, Y.T. Multi-Target drugs: The trend of drug research and development. PLoS One 7, e40262 (2012
2. Huang, R., Wallqvist, A., Thanki, N. & Covell, D.G. Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action. Pharmacogenomics J. 5, 381-399 (2005
3. Chen, X. et al. A sub-pathway-based approach for identifying drug response principal network. Bioinformatics 27, 649-654 (2011
4. Ye, H., Yang, L., Cao, Z., Tang, K. & Li, Y. A pathway profile-based method for drug repositioning. Chinese Science Bulletin 57, 2106-12 (2012
5. Silberberg, Y., Gottlieb, A., Kupiec, M., Ruppin, E. & Sharan, R. Large-scale elucidation of drug response pathways in humans. J. Comput. Biol. 19, 163-174 (2012
6. Cooper, G.M. et al. A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood 112, 1022-1027 (2008
7. Baldwin, R.M. et al. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin. Cancer Res. 18, 5099-5109 (2012
8. Innocenti, F. et al. A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Clin. Cancer Res. 18, 577-584 (2012
9. Jung, K. et al. Automated detection of off-label drug use. PloS One, 9(2), e89324 (2014
10. Gottlieb, A., Stein, G.Y., Oron, Y., Ruppin, E. & Sharan, R. INDI: A computational framework for inferring drug interactions and their associated recommendations. Mol. Syst. Biol. 8, 592 (2012
11. Wang, Y. et al. An overview of the PubChem BioAssay resource. Nucleic Acids Res. 38, D255-D266 (2010
12. Friday, K.E., Dong, C. & Fontenot, R.U. Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes. J. Clin. Endocrinol. Metab. 86, 48-52 (2001
13. Busch Sørensen, M., Sjøstrand, H., Sengeløv, H., Tiefenthal Thrane, M., Juul Holst, J. & Lyngsøe, J. Influence of short term verapamil treatment on glucose metabolism in patients with non-insulin dependent diabetes mellitus. Eur. J. Clin. Pharmacol. 41, 401-404 (1991
14. He, P., Cheng, X., Staufenbiel, M., Li, R. & Shen, Y. Long-Term treatment of thalidomide ameliorates amyloid-like pathology through inhibition of ®-secretase in a mouse model of Alzheimer's disease. PloS One 8, e55091 (2013
15. Thun, M.J., Namboodiri, M.M. & Heath, C.W. Jr. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325, 1593-1596 (1991
16. Evans, J.F. Rofecoxib (Vioxx), a specific cyclooxygenase-2 inhibitor, is chemopreventive in a mouse model of colon cancer. Am. J. Clin. Oncol. 26, S62-S65 (2003
17. Kuendgen, A. & Gattermann, N. Valproic acid for the treatment of myeloid malignancies. Cancer 110, 943-954 (2007
18. Coyle, T.E., Bair, A.K., Stein, C., Vajpayee, N., Mehdi, S. & Wright, J. Acute leukemia associated with valproic acid treatment: A novel mechanism for leukemogenesis? Am. J. Hematol. 78, 256-260 (2005
19. Wang, C.Y., Zhong, W.B., Chang, T.C., Lai, S.M. & Tsai, Y.F. Lovastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, induces apoptosis and differentiation in human anaplastic thyroid carcinoma cells. J. Clin. Endocrinol. Metab. 88, 3021-3026 (2003
20. Zhong, W.B., Hsu, S.P., Ho, P.Y., Liang, Y.C., Chang, T.C. & Lee, W.S. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway. Biochem. Pharmacol. 82, 1663-1672 (2011
21. McCord, E.L. & Goenka, S. Development of thyroid follicular adenoma on simvastatin therapy. Tenn. Med. 93, 210-212 (2000
22. Robison, R.L., Suter, W. & Cox, R.H. Carcinogenicity and mutagenicity studies with fluvastatin, a new, entirely synthetic HMG-CoA reductase inhibitor. Fundam. Appl. Toxicol. 23, 9-20 (1994
23. Friedman, G.D., Flick, E.D., Udaltsova, N., Chan, J., Quesenberry, C.P. Jr & Habel, L.A. Screening statins for possible carcinogenic risk: Up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol. Drug Saf. 17, 27-36 (2008
24. Hamad, A.M., Sutcliffe, A.M. & Knox, A.J. Aspirin-induced asthma: Clinical aspects, pathogenesis and management. Drugs 64, 2417-2432 (2004
25. Bolland, M.J. et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: Meta-Analysis. BMJ 341, c3691 (2010
26. Shah, K., Gupta, S., Ghosh, J., Bajpai, J. & Maheshwari, A. Acute non-ST elevation myocardial infarction following paclitaxel administration for ovarian carcinoma: A case report and review of literature. J. Cancer Res. Ther. 8, 442-444 (2012
27. Kitano, H. A robustness-based approach to systems-oriented drug design. Nature Reviews Drug Discovery 5, 202-210 (2007
28. Csermely, P., Korcsmáros, T., Kiss, H.J., London, G. & Nussinov, R. Structure and dynamics of molecular networks: A novel paradigm of drug discovery: A comprehensive review. Pharmacol Ther 138, 333-408 (2013
29. Breitkreutz, B.J. et al. The BioGRID Interaction Database: 2008 update. Nucleic Acids Res. 36, D637-D640 (2008
30. Xenarios, I., Salwínski, L., Duan, X.J., Higney, P., Kim, S.M. & Eisenberg, D. DIP, the Database of Interacting Proteins: A research tool for studying cellular networks of protein interactions. Nucleic Acids Res. 30, 303-305 (2002
31. Prasad, T.S.K. et al. Human protein reference database-2009 update. Nucleic Acids Res 37, D767-D72 (2009
32. Kerrien, S. et al. The IntAct molecular interaction database in 2012. Nucleic Acids Res. 40, D841-D846 (2012
33. Chatr-Aryamontri, A. et al. MINT: The Molecular INTeraction database. Nucleic Acids Res. 35, D572-D574 (2007
34. Mewes, H.W. et al. MIPS: A database for genomes and protein sequences. Nucleic Acids Res. 30, 31-34 (2002
35. Schaefer, M.H., Fontaine, J.F., Vinayagam, A., Porras, P., Wanker, E.E. & Andrade-Navarro, M.A. HIPPIE: Integrating protein interaction networks with experiment based quality scores. PLoS One 7, e31826 (2012
36. Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M. & Hirakawa, M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38, D355-D360 (2010
37. Lachmann, A., Xu, H., Krishnan, J., Berger, S.I., Mazloom, A.R. & Máayan, A. ChEA: Transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26, 2438-2444 (2010
38. Schaefer, C.F. et al. PID: The Pathway Interaction Database. Nucleic Acids Res. 37, D674-D679 (2009
39. Matthews, L. et al. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res. 37, D619-D622 (2009
40. Nishimura, D. BioCarta. Biotech Software & Internet Report 2, 117-120 (2001
41. Klein, T.E. et al. Integrating genotype and phenotype information: An overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J. 1, 167-170 (2001
42. Wishart, D.S. et al. DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36, D901-D906 (2008
43. Hamosh, A., Scott, A.F., Amberger, J., Bocchini, C., Valle, D. & McKusick, V.A. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 30, 52-55 (2002
44. Gottlieb, A., Stein, G.Y., Ruppin, E. & Sharan, R. PREDICT: A method for inferring novel drug indications with application to personalized medicine. Mol. Syst. Biol. 7, 496 (2011
45. Kuhn, M., Campillos, M., Letunic, I., Jensen, L.J. & Bork, P. A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol. 6, 343 (2010
46. Drugsite Trust. Drugs.com™: Drug interactions checker. (cited 3 July 2011). http://www.drugs.com/drug-interactions.html
47. Jaccard, P. Nouvelles recherches sur la distribution florale. Bul Soc Vaudoise Sci Nat 44, 223-270 (1908
48. Dhillon, I.S. Co-clustering documents and words using bipartite spectral graph partitioning. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, San Francisco, CA, 26-29 August 2001. 269-274 (2001
49. Bodenreider, O. The Unified Medical Language System (UMLS): Integrating biomedical terminology. Nucleic Acids Res. 32, D267-D270 (2004